TACHIPIRINA 500 mg compresse, OKi 80 mg granulato per soluzione orale, KLS-GABA 40mg-17mg, KLS-GABA 80mg-34mg clinical trials

A phase 2, multicenter, randomized, double blind, active controlled, parallel group study assessing the analgesic effect and safety of two doses of DFL24412 in patients with chronic low back pain compared to Ketoprofen Lysine Salt (KLS)

This study is testing different doses of a new medicine (DFL24412) for long-lasting lower back pain. Researchers want to see if it reduces pain and is safe, comparing it to a common painkiller called Ketoprofen Lysine Salt.